When does a DCF/NPV understate value, and how do real options capture what it misses?
An advanced Valuation question — expect it in final rounds and case-heavy interviews (IB, PE, Big-4 Transaction Services).
THE SHORT ANSWER
A standard DCF discounts a single expected cash-flow path and implicitly assumes management commits today and does nothing as the future unfolds — so it ignores the value of flexibility under uncertainty. Real options capture managerial flexibility: the option to expand if a project succeeds, to abandon and recover salvage if it fails, to defer/wait for information, to switch inputs/outputs, or to stage investment. Because these are asymmetric (you invest more only in good states, cut losses in bad ones), they add value that a static NPV — which averages over outcomes — misses, and the value rises with uncertainty (more volatility = more option value), the opposite of how a discount-rate-penalized DCF treats risk. They matter most for R&D, natural resources (develop when prices are high), staged/phased investments, and start-ups, where flexibility is the main value. You quantify them with option-pricing logic (Black-Scholes-style or binomial/decision trees). The caveat: real options can be over-applied to justify weak projects, and the inputs (volatility, the option's exercisability) are hard to estimate — so use them where genuine flexibility and uncertainty exist.
WHAT INTERVIEWERS LISTEN FOR
- ✓DCF assumes a committed single path, ignores flexibility
- ✓Real options value expand/abandon/defer/switch/stage decisions
- ✓Asymmetric payoffs add value; value rises with uncertainty
- ✓Use for R&D/resources/staged/start-ups; beware over-application/input difficulty
COMMON MISTAKES
- ✗Claiming DCF always captures all value
- ✗Thinking more uncertainty always lowers value
- ✗Over-using real options to justify weak projects
Reading isn't the same as answering under pressure.
Interviewers don't hand you the model answer — you deliver yours on a clock. Practice this and 1,000+ questions with AI feedback on every answer.
RELATED QUESTIONS
- How do you value a company with no revenue?
- Explain accretion/dilution analysis.
- How would you value a company in a cyclical industry?
- What is the most appropriate valuation methodology for a company with significant intangible assets but no current revenue, such as a biotech startup in the pre-clinical stage?
- When calculating WACC for a company with multiple divisions in different countries, what is the correct approach?
- How does a private equity buyer use an LBO to set the maximum price it can pay, and why is this a valuation floor?